INGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ingredion Inc (INGR) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong positioning in health and wellness trends, positive hedge fund activity, and favorable analyst ratings with a recovery expected in earnings growth make it a compelling choice. Despite some recent headwinds, the long-term outlook remains positive.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 59.369, and moving averages are converging, suggesting no strong trend. Current price is near resistance levels (R1: 112.918), but the overall technical setup leans slightly bullish.
Hedge funds are significantly increasing their holdings, with a 137.50% increase in buying activity last quarter.
Analysts have initiated or maintained positive ratings with price targets as high as $130, indicating potential upside.
The company's focus on health and wellness trends positions it well for long-term growth.
Recent financials show a slight revenue decline (-2.39% YoY) and gross margin drop (-1.88% YoY), although net income and EPS have grown significantly.
Facility-specific headwinds have impacted earnings in the short term.
In Q4 2025, revenue dropped by 2.39% YoY to $1.757 billion, but net income surged by 73.68% YoY to $165 million. EPS increased by 79.72% YoY to 2.57, reflecting strong profitability despite weaker gross margins (-1.88% YoY).
Benchmark initiated a Buy rating with a $130 price target, citing the company's strong positioning in health and wellness trends. UBS raised its price target to $124, while Barclays increased it to $128. Analysts expect earnings recovery by 2027, making it a solid long-term investment.
